• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青光眼手术后调节瘢痕形成过程的药理学方法。

Pharmacological Approaches to Modulate the Scarring Process after Glaucoma Surgery.

作者信息

Collotta Debora, Colletta Simona, Carlucci Virginia, Fruttero Claudia, Fea Antonio Maria, Collino Massimo

机构信息

Department of Neurosciences "Rita Levi Montalcini", University of Turin, 10126 Turin, Italy.

Chemsafe S.r.l., Via Ribes 5, 10010 Colleretto Giacosa, Italy.

出版信息

Pharmaceuticals (Basel). 2023 Jun 19;16(6):898. doi: 10.3390/ph16060898.

DOI:10.3390/ph16060898
PMID:37375845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10305204/
Abstract

Glaucoma is an acquired optic neuropathy that results in a characteristic optic nerve head appearance and visual field loss. Reducing the IOP is the only factor that can be modified, and the progression of the disease can be managed through medication, laser treatment, or surgery. Filtering procedures are used when target pressure cannot be obtained with less invasive methods. Nevertheless, these procedures require accurate control of the fibrotic process, which can hamper filtration, thus, negatively affecting the surgical success. This review explores the available and potential pharmacological treatments that modulate the scarring process after glaucoma surgery, analyzing the most critical evidence available in the literature. The modulation of scarring is based on non-steroidal anti-inflammatory drugs (NSAIDs), mitomycin, and 5-fluorouracil. In the long term, the failure rate of filtering surgery is mainly due to the limitations of the current strategies caused by the complexity of the fibrotic process and the pharmacological and toxicological aspects of the drugs that are currently in use. Considering these limitations, new potential treatments were investigated. This review suggests that a better approach to tackle the fibrotic process may be to hit multiple targets, thus increasing the inhibitory potential against excessive scarring following surgery.

摘要

青光眼是一种获得性视神经病变,会导致特征性的视神经乳头外观和视野缺损。降低眼压是唯一可以改变的因素,并且可以通过药物、激光治疗或手术来控制疾病的进展。当采用侵入性较小的方法无法达到目标眼压时,会使用滤过手术。然而,这些手术需要精确控制纤维化过程,因为纤维化会阻碍滤过,从而对手术成功率产生负面影响。这篇综述探讨了可用于调节青光眼手术后瘢痕形成过程的现有和潜在药物治疗方法,并分析了文献中最关键的证据。瘢痕形成的调节基于非甾体抗炎药(NSAIDs)、丝裂霉素和5-氟尿嘧啶。从长期来看,滤过手术的失败率主要是由于当前策略存在局限性,这些局限性是由纤维化过程的复杂性以及目前使用药物的药理和毒理学方面的问题所导致的。考虑到这些局限性,人们对新的潜在治疗方法进行了研究。这篇综述表明,应对纤维化过程的更好方法可能是针对多个靶点,从而增强对手术后过度瘢痕形成的抑制潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9492/10305204/467e458bbcce/pharmaceuticals-16-00898-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9492/10305204/479f6c0094e7/pharmaceuticals-16-00898-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9492/10305204/467e458bbcce/pharmaceuticals-16-00898-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9492/10305204/479f6c0094e7/pharmaceuticals-16-00898-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9492/10305204/467e458bbcce/pharmaceuticals-16-00898-g002.jpg

相似文献

1
Pharmacological Approaches to Modulate the Scarring Process after Glaucoma Surgery.青光眼手术后调节瘢痕形成过程的药理学方法。
Pharmaceuticals (Basel). 2023 Jun 19;16(6):898. doi: 10.3390/ph16060898.
2
[Aiming for zero blindness].追求零失明
Nippon Ganka Gakkai Zasshi. 2015 Mar;119(3):168-93; discussion 194.
3
[5-fluorouracil in the treatment of postoperative glaucoma].[5-氟尿嘧啶治疗术后青光眼]
Srp Arh Celok Lek. 1996 Jul-Aug;124(7-8):190-2.
4
Current and Future Techniques in Wound Healing Modulation after Glaucoma Filtering Surgeries.青光眼滤过性手术后伤口愈合调节的当前及未来技术
Open Ophthalmol J. 2016 Feb 29;10:68-85. doi: 10.2174/1874364101610010068. eCollection 2016.
5
Animal models and drug candidates for use in glaucoma filtration surgery: A systematic review.用于青光眼滤过手术的动物模型和药物候选物:系统评价。
Exp Eye Res. 2022 Apr;217:108972. doi: 10.1016/j.exer.2022.108972. Epub 2022 Jan 31.
6
A role for antimetabolites in glaucoma tube surgery: current evidence and future directions.抗代谢药物在青光眼引流管手术中的作用:当前证据与未来方向。
Curr Opin Ophthalmol. 2016 Mar;27(2):164-9. doi: 10.1097/ICU.0000000000000244.
7
8
Basic science and clinical aspects of wound healing in glaucoma filtering surgery.青光眼滤过手术中伤口愈合的基础科学与临床方面
J Ocul Pharmacol Ther. 1998 Feb;14(1):75-95. doi: 10.1089/jop.1998.14.75.
9
[Current topics in glaucoma].[青光眼的当前主题]
Nippon Ganka Gakkai Zasshi. 1996 Dec;100(12):923-36.
10
[Pharmacological modulation of wound healing in glaucoma surgery].[青光眼手术中伤口愈合的药理学调节]
Vestn Oftalmol. 2022;138(4):136-143. doi: 10.17116/oftalma2022138041136.

引用本文的文献

1
Use of Mitomycin C in Ophthalmic Surgery.丝裂霉素C在眼科手术中的应用。
J Curr Ophthalmol. 2025 Jun 5;36(3):211-222. doi: 10.4103/joco.joco_283_23. eCollection 2024 Jul-Sep.
2
Fighting Bleb Fibrosis After Glaucoma Surgery: Updated Focus on Key Players and Novel Targets for Therapy.青光眼手术后对抗滤过泡纤维化:对关键因素和新型治疗靶点的最新关注
Int J Mol Sci. 2025 Mar 5;26(5):2327. doi: 10.3390/ijms26052327.
3
Plasma rich in growth factors (PRGF) technology as adjuvant to Ab Externo trabeculectomy.富血小板血浆(PRGF)技术作为外滤过性小梁切除术的辅助手段。

本文引用的文献

1
[Pharmacological modulation of wound healing in glaucoma surgery].[青光眼手术中伤口愈合的药理学调节]
Vestn Oftalmol. 2022;138(4):136-143. doi: 10.17116/oftalma2022138041136.
2
Exosome-mediated aptamer S58 reduces fibrosis in a rat glaucoma filtration surgery model.外泌体介导的适配体S58减轻大鼠青光眼滤过手术模型中的纤维化。
Int J Ophthalmol. 2022 May 18;15(5):690-700. doi: 10.18240/ijo.2022.05.02. eCollection 2022.
3
Application of Nd:YAG laser to the anterior vitreous in malignant glaucoma - a systemic review and meta-analysis.
Int Ophthalmol. 2024 Jul 22;44(1):332. doi: 10.1007/s10792-024-03253-z.
4
Wound Modulations in Glaucoma Surgery: A Systematic Review.青光眼手术中的伤口调节:一项系统评价
Bioengineering (Basel). 2024 Apr 30;11(5):446. doi: 10.3390/bioengineering11050446.
5
The Effect of Trabecular Aspiration on Intraocular Pressure, Medication and the Need for Further Glaucoma Surgery in Eyes with Pseudoexfoliation Glaucoma.小梁抽吸术对假性剥脱性青光眼患者眼压、药物治疗及进一步青光眼手术需求的影响
Diseases. 2024 May 6;12(5):92. doi: 10.3390/diseases12050092.
6
Pharmacological Stimulation of Soluble Guanylate Cyclase Counteracts the Profibrotic Activation of Human Conjunctival Fibroblasts.药理学刺激可溶性鸟苷酸环化酶可拮抗人结膜成纤维细胞的促纤维化激活。
Cells. 2024 Feb 18;13(4):360. doi: 10.3390/cells13040360.
7
Randomised clinical trial for morphological changes of trabecular meshwork between Kahook dual-blade goniotomy and ab interno trabeculotomy with a microhook.随机临床试验:卡胡刀双刀刃小梁切开术与微钩内路小梁切开术治疗小梁网形态变化的比较。
Sci Rep. 2023 Nov 27;13(1):20783. doi: 10.1038/s41598-023-48121-5.
8
Immunomodulatory and Antioxidant Drugs in Glaucoma Treatment.青光眼治疗中的免疫调节和抗氧化药物
Pharmaceuticals (Basel). 2023 Aug 22;16(9):1193. doi: 10.3390/ph16091193.
Nd:YAG 激光在前部玻璃体恶性青光眼的应用——系统评价和荟萃分析。
Graefes Arch Clin Exp Ophthalmol. 2022 Sep;260(9):2981-2990. doi: 10.1007/s00417-022-05640-7. Epub 2022 Mar 29.
4
Oncosuppressive roles of decorin through regulation of multiple receptors and diverse signaling pathways.核心聚糖通过调节多种受体和不同的信号通路发挥抑瘤作用。
Am J Physiol Cell Physiol. 2022 Mar 1;322(3):C554-C566. doi: 10.1152/ajpcell.00016.2022. Epub 2022 Feb 16.
5
Preparing the ocular surface for glaucoma filtration surgery: an unmet clinical need.为青光眼滤过手术准备眼表:一项未被满足的临床需求。
Acta Ophthalmol. 2022 Nov;100(7):740-751. doi: 10.1111/aos.15098. Epub 2022 Jan 28.
6
Assessing safety and success after using bevacizumab, 5-fluorouracil or placebo in primary trabeculectomy. A prospective randomized placebo controlled 1-year follow-up study.评估在原发性小梁切除术中使用贝伐单抗、5-氟尿嘧啶或安慰剂后的安全性和成功率。一项前瞻性随机安慰剂对照的1年随访研究。
Cutan Ocul Toxicol. 2022 Mar;41(1):25-32. doi: 10.1080/15569527.2021.2003376. Epub 2022 Jan 25.
7
Nonsteroidal anti-inflammatory drugs for retinal neurodegenerative diseases.非甾体类抗炎药治疗视网膜神经退行性疾病。
Prostaglandins Other Lipid Mediat. 2021 Oct;156:106578. doi: 10.1016/j.prostaglandins.2021.106578. Epub 2021 Jul 7.
8
Novel Benzyloxyphenyl Pyrimidine-5-Carbonitrile Derivatives as Potential Apoptotic Antiproliferative Agents.新型苯氧苯基嘧啶-5-甲腈衍生物作为潜在的凋亡性抗增殖剂。
Anticancer Agents Med Chem. 2022;22(5):978-990. doi: 10.2174/1871520621666210612043812.
9
A novel ocular function for decorin in the aqueous humor outflow.decorin 在房水中的一种新的眼功能。
Matrix Biol. 2021 Mar;97:1-19. doi: 10.1016/j.matbio.2021.02.002. Epub 2021 Feb 11.
10
History, presence, and future of mitomycin C in glaucoma filtration surgery.丝裂霉素 C 在青光眼滤过手术中的历史、现状和未来。
Curr Opin Ophthalmol. 2021 Mar 1;32(2):148-159. doi: 10.1097/ICU.0000000000000729.